TScan Therapeutics Price Chart
TScan Therapeutics Volume Chart
TScan Therapeutics Market Segments
Regular Trading Hours
+0.04(+3.27%)
| Open | $1.07 |
|---|---|
| Close | $1.11 |
| Low | $1.06 |
| Low Change | -0.02 (-1.40%) |
| High | $1.14 |
| High Change | +0.07 (+6.54%) |
| Range | $0.09 |
| Volume | 690.704K |
| Dollar Volume | $763.23K |
Premarket
+0.02(+1.84%)
| Open | $1.08 |
|---|---|
| Close | $1.10 |
| Low | $1.08 |
| Low Change | 0.00 (0.00%) |
| High | $1.10 |
| High Change | +0.02 (+1.84%) |
| Range | $0.02 |
| Volume | 5.718K |
| Dollar Volume | $6.29K |
After Hours Yesterday
+0.00(+0.08%)
| Open | $1.10 |
|---|---|
| Close | $1.10 |
| Low | $1.06 |
| Low Change | -0.04 (-3.56%) |
| High | $1.10 |
| High Change | +0.00 (+0.08%) |
| Range | $0.04 |
| Volume | 5.47K |
| Dollar Volume | $6.02K |
Regular Trading Hours Yesterday
-0.02(-1.83%)
| Open | $1.09 |
|---|---|
| Close | $1.07 |
| Low | $1.04 |
| Low Change | -0.05 (-4.58%) |
| High | $1.10 |
| High Change | +0.01 (+0.92%) |
| Range | $0.06 |
| Volume | 448.854K |
| Dollar Volume | $480.27K |
Premarket Yesterday
+0.04(+3.81%)
| Open | $1.05 |
|---|---|
| Close | $1.09 |
| Low | $1.05 |
| Low Change | 0.00 (0.00%) |
| High | $1.10 |
| High Change | +0.05 (+4.70%) |
| Range | $0.05 |
| Volume | 10.467K |
| Dollar Volume | $11.41K |
TScan Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.12 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.12 |
| 20 Day Moving Average (SMA20) | $1.09 |
| 50 Day Moving Average (SMA50) | $1.08 |
| 100 Day Moving Average (SMA100) | $1.16 |
| 200 Day Moving Average (SMA200) | $1.47 |
TScan Therapeutics Statistics
| Average Volume (30 Days) | 546.02K |
|---|---|
| P/E Ratio (Current) | -.46 |
| EPS (Current) | -$2.28 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$139.73M |
| Cash Ratio | 8.15 |
| Current Ratio | 8.41 |
| Quick Ratio | 8.41 |
| Debt to Equity | 0.26 |
| Enterprise Value | -$60.13M |
| EV to EBITDA | 0.45 |
| EV to Sales | -5.82 |
| Price to Book | 0.49 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 5.79 |
| Return on Assets | -0.57% |
| Return on Equity | -1.05% |
TScan Therapeutics Stock Splits
There have been no stock splits for TScan Therapeutics (TCRX).
TScan Therapeutics Dividends
There have been no dividends for TScan Therapeutics (TCRX).